0      0

The Global Pharmaceutical Manufacturing Leadership Forum 2021

ATMPs (Cell and Gene Therapy) Challenges and Opportunities for this Emerging Modality and Panel Discussion


May 18, 2021 8:25am ‐ May 18, 2021 9:50am


Speaker(s):

  • James A. Breen, PE, Vice President, Lead Biologics Expansion, Janssen Pharmaceuticals
  • Frances M. Zipp, President & CEO, Lachman Consultant Services
  • Ryan Larson, Ph.D., Senior Director, Cell Therapy Product and Analytical Development, Bristol Myers Squibb
  • Kathy Francissen, Ph.D., Executive Director, Biologics Development, CMC Regulatory, Genentech
  • Steven Oh, Ph.D., Deputy Director, Division of Cellular and Gene Therapies, FDA/CBER/OTAT
  • Stefanos Grammatikos, Ph.D., Vice President – Head of Biotech Sciences, UCB Pharma (Belgium) /UCB Celltech (UK)

You must be logged in and own this session in order to post comments.